Trial intelligence / Profile preview

Norethisterone for Prolonged Bleeding in ENG-Implant Users

NCT04047875Phase 4Completed

Sponsor
Universidade de São Paulo
Start
Sep 2020
Primary completion
May 2023
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of norethindrone in breakthrough bleeding, sponsored by Universidade de São Paulo. Started Sep 2020; status: completed.

02

Drugs

norethindrone
03

Conditions

breakthrough bleeding

Beyond the preview

Go deeper on NCT04047875.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04047875.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call